Arlington Capital Partners acquires Molecular Products
Arlington Capital Partners (Arlington Capital), a Washington, DC-based private equity firm, has acquired Molecular Products Group. Headquartered in Harlow, Essex, UK, Molecular Products is a manufacturer of advanced chemistry-based products serving the healthcare, defence and industrial markets. The Company primarily specialises in the manufacture and supply of chemical technologies for

